Human herpesvirus 6 involvement in paediatric drug hypersensitivity syndrome

J Ahluwalia1, K Abuabara, M J Perman

  • 1Department of Pediatrics, Division of General Pediatrics, Section of Dermatology, The Children's Hospital of Philadelphia, 3550 Market Street, 2nd Floor, Philadelphia, 19104, PA, U.S.A.

Insights

Human herpesvirus 6 (HHV6) positivity in children with drug hypersensitivity syndrome (DHS) indicates a more severe illness. Corticosteroid treatment may shorten illness duration in these patients.

Area of Science:

  • Infectious Diseases
  • Dermatology
  • Pharmacology

Background:

  • Human herpesvirus 6 (HHV6) positivity may worsen drug hypersensitivity syndrome (DHS) severity.
  • Systemic corticosteroids are speculated to prolong DHS duration in HHV6-positive patients.

Purpose of the Study:

  • To compare DHS severity in pediatric patients with and without HHV6 reactivation.
  • To evaluate the efficacy of systemic corticosteroid treatment in HHV6-positive DHS patients.

Main Methods:

  • Retrospective case series of 29 pediatric inpatients with DHS.
  • Patients were tested for HHV6 and stratified by HHV6 status and corticosteroid treatment.
  • Disease severity assessed by hospital length of stay (LOS), febrile days (Tfeb), and cessation of progression (CTP).

Main Results:

  • HHV6-positive patients had significantly longer LOS, Tfeb, and CTP compared to HHV6-negative patients.
  • Systemic corticosteroids were administered to all HHV6-positive and most HHV6-negative patients.
  • In HHV6-negative patients, corticosteroids significantly reduced CTP and showed a trend toward reduced LOS and Tfeb.

Conclusions:

  • HHV6 positivity is linked to more severe DHS in children.
  • Systemic corticosteroids may reduce illness severity and duration in DHS patients, particularly in HHV6-negative cases.
Abstract

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
199
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.1K
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
247
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
196
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
333